[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Techne Corp (TECH)

Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Are Wall Street Analysts Bullish on Bio-Techne Stock?

With a market cap of $7.5 billion, Bio-Techne Corporation (TECH) is a global life sciences company that develops, manufactures, and sells reagents, instruments, and services for research, diagnostics, and bioprocessing applications. It operates through its Protein Sciences and Diagnostics and Spatial Biology segments, providing innovative solutions for life science research, cell and gene therapy, molecular diagnostics, and spatial biology.

Shares of Bio-Techne have lagged behind the broader market over the past 52 weeks. HCA stock has risen 1.9% over this time frame, while the broader S&P 500 Index ($SPX) has gained 27.9%. In addition, the stock has declined 18% on a...

Fundamentals

See More
  • Market Capitalization, $K 7,548,191
  • Shares Outstanding, K 156,569
  • Annual Sales, $ 1,220 M
  • Annual Income, $ 73,400 K
  • EBIT $ 154 M
  • EBITDA $ 264 M
  • 60-Month Beta 1.41
  • Price/Sales 6.08
  • Price/Cash Flow 19.38
  • Price/Book 3.56

Options Overview Details

View History
  • Implied Volatility 48.11% (-3.24%)
  • Historical Volatility 77.71%
  • IV Percentile 39%
  • IV Rank 42.00%
  • IV High 63.80% on 04/29/26
  • IV Low 36.75% on 09/16/25
  • Expected Move (DTE 24) 5.52 (11.44%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 154
  • Volume Avg (30-Day) 418
  • Put/Call OI Ratio 1.11
  • Today's Open Interest 3,594
  • Open Int (30-Day) 10,704
  • Expected Range 42.69 to 53.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.49
  • Number of Estimates 6
  • High Estimate $0.53
  • Low Estimate $0.41
  • Prior Year $0.51
  • Growth Rate Est. (year over year) -3.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.19 +11.61%
on 05/15/26
57.56 -16.25%
on 04/23/26
-10.37 (-17.70%)
since 04/22/26
3-Month
43.19 +11.61%
on 05/15/26
62.47 -22.83%
on 04/21/26
-9.31 (-16.19%)
since 02/20/26
52-Week
43.19 +11.61%
on 05/15/26
72.16 -33.19%
on 01/22/26
+0.89 (+1.88%)
since 05/22/25

Most Recent Stories

More News
Are Wall Street Analysts Bullish on Bio-Techne Stock?

While Bio-Techne has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

TECH : 48.21 (+1.77%)
XLV : 149.89 (+1.17%)
$SPX : 7,473.47 (+0.37%)
2 Healthcare Stocks to Research Further and 1 We Find Risky

2 Healthcare Stocks to Research Further and 1 We Find Risky

TECH : 48.21 (+1.77%)
HCA : 394.07 (+0.38%)
RMD : 208.05 (-0.45%)
The 5 Most Interesting Analyst Questions From Bio-Techne’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From Bio-Techne’s Q1 Earnings Call

TECH : 48.21 (+1.77%)
1 Cash-Producing Stock Worth Investigating and 2 We Turn Down

1 Cash-Producing Stock Worth Investigating and 2 We Turn Down

TECH : 48.21 (+1.77%)
GLW : 194.05 (+1.13%)
SLB : 57.28 (+0.05%)
TECH Q1 Deep Dive: Biotech Weakness and Order Timing Drive Top-Line Miss

TECH Q1 Deep Dive: Biotech Weakness and Order Timing Drive Top-Line Miss

TECH : 48.21 (+1.77%)
Bio-Techne (NASDAQ:TECH) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings

Bio-Techne (NASDAQ:TECH) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings

TECH : 48.21 (+1.77%)
Techne: Fiscal Q3 Earnings Snapshot

Techne: Fiscal Q3 Earnings Snapshot

TECH : 48.21 (+1.77%)
Bio-Techne Declares Dividend

MINNEAPOLIS , May 6, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March...

TECH : 48.21 (+1.77%)
Bio-Techne Releases Third Quarter Fiscal 2026 Results

MINNEAPOLIS , May 6, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ending March 31, 2026.

TECH : 48.21 (+1.77%)
Bio-Techne: Wall Street's Biotech Funding Recovery Thesis Ignores What Customers Are Actually Saying

Barchart Research What to Expect from TECH Earnings TECH Generated May 5, 2026 Current Price $56.68 EPS Estimate $$0.48 Consensus Rating Moderate Buy Average Move 6.99% Bio-Techne: Wall Street's Biotech...

TECH : 48.21 (+1.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

3rd Resistance Point 49.78
2nd Resistance Point 49.02
1st Resistance Point 48.62
Last Price 48.21
1st Support Level 47.46
2nd Support Level 46.70
3rd Support Level 46.30

See More

52-Week High 72.16
Fibonacci 61.8% 61.10
Fibonacci 50% 57.68
Fibonacci 38.2% 54.26
Last Price 48.21
52-Week Low 43.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.